soul trial oral semaglutide cardiovascular outcomes results 2025 nejm and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized ADA 2025: Oral Semaglutide Demonstrates

Emerging research is also exploring whether long-term use could be linked to pancreatic issues or gallbladder disease, though more studies are needed

Physical Function Results WOMAC physical function subscale (baseline 5.8 points, scale 010): Both retatrutide doses produced reductions in the physical function subscale exceeding 70% meaning patients could perform daily activities with substantially less difficulty than at baseline

For healthcare marketers, this change extends well beyond reimbursement policy

Neither is identical to brand-name Mounjaro, and that difference is both intentional and legally necessary

Lipids Health Dis 16:113 Ozcicek F, Kara AV, Akbas EM, Kurt N, Yazici GN, Cankaya M, Mammadov R, Ozcicek A, Suleyman H (2020) Effects of Anakinra on the small intestine mucositis induced by methotrexate in rats